Insiders · Profile

Apuli Maricel

Chief Accounting Officer at BridgeBio Pharma. Filing since 2 May 2025. CIK 0002058197

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jul 2026
Chief Accounting Officer
Sold on a plan
2,000
$160.12K
1.5%
30 Apr 2026
Chief Accounting Officer
Sold on a plan
2,000
$143.16K
1.5%
26 Feb 2026
Chief Accounting Officer
Sold on a plan
2,000
$132.00K
1.6%
17 Feb 2026
Chief Accounting Officer
Sold on a plan
510
$37.90K
0.4%
8 Dec 2025
Chief Accounting Officer
Sold on a plan
2,000
$148.52K
1.5%
7 Aug 2025
Chief Accounting Officer
Sold at will
1,000
$45.44K
0.7%
2 May 2025
Chief Accounting Officer
Sold at will
1,026
$39.51K
0.7%
7 decisions on file.